Publicacions en què col·labora amb María Blanco Prieto (9)

2022

  1. In vivo biodistribution of edelfosine-loaded lipid nanoparticles radiolabeled with Technetium-99 m: Comparison of administration routes in mice

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 175, pp. 1-6

2016

  1. Lipid nanoparticles enhance the absorption of cyclosporine A through the gastrointestinal barrier: In vitro and in vivo studies

    International Journal of Pharmaceutics, Vol. 500, Núm. 1-2, pp. 154-161

2014

  1. Edelfosine lipid nanoparticles overcome multidrug resistance in K-562 leukemia cells by a caspase-independent mechanism

    Molecular Pharmaceutics, Vol. 11, Núm. 8, pp. 2650-2658

  2. In vitro intestinal co-culture cell model to evaluate intestinal absorption of Edelfosine lipid nanoparticles

    Current Topics in Medicinal Chemistry, Vol. 14, Núm. 9, pp. 1124-1132

  3. Lipid nanoparticles protect from edelfosine toxicity in vivo

    International Journal of Pharmaceutics, Vol. 474, Núm. 1-2, pp. 1-5

2013

  1. Edelfosine lipid nanosystems overcome drug resistance in leukemic cell lines

    Cancer Letters, Vol. 334, Núm. 2, pp. 302-310

  2. Efficacy of edelfosine lipid nanoparticles in breast cancer cells

    International Journal of Pharmaceutics, Vol. 454, Núm. 2, pp. 720-726

2012

  1. Lipid nanoparticles for cancer therapy: State of the art and future prospects

    Expert Opinion on Drug Delivery, Vol. 9, Núm. 10, pp. 1245-1261

2011

  1. Lipid Nanoparticles in Biomedicine

    Encyclopedia of Nanoscience and Nanotechnology (American Scientific Publishers), pp. 455 - 478